Utility of Induced Pluripotent Stem Cell-Based Microphysiological Systems for Drug Development and Testing

Area of Science:

• Biotechnology
• Drug Development
• Tissue Engineering

Background:

• Microphysiological systems (MPS) are miniaturized biological mimics designed to replicate organ and tissue functions.
• Current MPS development often prioritizes microarchitecture and technological design over biological functionality.
• The potential of MPS to accelerate drug development hinges on their ability to accurately model in vivo responses.

Purpose of the Study:

• To discuss the essential prerequisites for designing and constructing MPS for drug development.
• To evaluate the utility of MPS in a holistic manner for drug testing.
• To highlight limitations and areas for improvement in current MPS technology.

Main Methods:

• Discussion of design and construction prerequisites for MPS.
• Consideration of induced pluripotent cells for mimicking in vivo disease conditions.
• Analysis of existing limitations and recent advancements in MPS technology.

Main Results:

• MPS show potential for drug development if they can accurately mimic organ responses and allow cellular monitoring.
• Technological advancements in MPS design have sometimes overshadowed biological relevance.
• Induced pluripotent cells are a key source for modeling disease states in MPS.

Conclusions:

• Optimizing MPS design requires a holistic approach balancing technological sophistication with biological fidelity.
• Further improvements are necessary to fully realize the potential of MPS in drug development and testing.
• The use of induced pluripotent cells holds significant promise for enhancing the in vivo relevance of MPS models.